Feedback survey

Thank you for your participation in the iBRCAf Pfizer symposium: Optimising mBC therapy in the era of PARP inhibitors. We hope that you found it useful. Your feedback is very important to us; we would appreciate it if you could complete this brief survey.

mBC, metastatic breast cancer; PARP, Poly (ADP-ribose) polymerase.

Pfizer Pte Ltd
80 Pasir Panjang Road, #16-81/82
Mapletree Business City, Singapore 117372
Tel: +65-6403 8888 Fax: +65-6403 8868 Website:
Intended for Healthcare Professionals only